Randomized, sham-controlled trial of intraoperative ticagrelor removal to reduce perioperative bleeding
Michael J. Mack, Richard Whitlock, Michael Kwok Lam Chu, Bradley Taylor et autres
OBJECTIVE: Patients on ticagrelor who are undergoing cardiac surgery before completing guideline-recommended washout are at high risk for severe bleeding. This study evaluated whether a novel drug removal device reduces bleeding in patients operated within 2 days from ticagrelor discontinuation. METHODS: Eligible …
us, ca (code pays fourni par la source)
1 citation
Journal of Thoracic and Cardiovascular Surgery